Preclinical Proof of Concept Studies for Rare Diseases
Due: June 2, 2026 This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition Read More